Asset Advisory Group’s Citius Pharmaceuticals CTXR Stock Holding History

Asset Advisory Group’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.7K	Hold	59,011	–	–	0.02%	124
2026 Q1	$53.1K	Hold	59,011	–	–	0.03%	115
2025 Q4	$45.9K	Buy	+59,011	New	+$73.8K	0.02%	119

Other funds holding CTXR

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Asset Advisory Group's CTXR Position: Q2 2026 in Review

Asset Advisory Group held its Citius Pharmaceuticals (CTXR) position steady in Q2 2026 at 59,011 shares worth $35.7K. The position accounts for 0.02% of the portfolio, ranked #124.

Asset Advisory Group first reported a position in CTXR in Q4 2025 and has held it in 3 quarters since. The position peaked at $53.1K in Q1 2026. 3 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

Asset Advisory Group held 59,011 shares of Citius Pharmaceuticals worth $35.7K as of Q2 2026.
Asset Advisory Group left its Citius Pharmaceuticals share count unchanged in Q2 2026.
Citius Pharmaceuticals made up 0.02% of Asset Advisory Group's portfolio in Q2 2026, its #124 holding.
Asset Advisory Group first reported a position in Citius Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
Asset Advisory Group's Citius Pharmaceuticals position peaked at $53.1K in Q1 2026.
3 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Asset Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.